Former FDA Head: Immunity From Omicron Likely ‘Protective Against’ New Variant; ‘Doesn’t Appear To Be’ More Virulent

Former FDA Head: Immunity From Omicron Likely ‘Protective Against’ New Variant; ‘Doesn’t Appear To Be’ More Virulent

On Friday, former FDA Commissioner and current Pfizer board member Dr. Scott Gottlieb appeared on CNBC’s “Squawk Pod” to discuss COVID-19 and the latest variant, a sub-variant of Omicron.

When asked what Americans should know about the latest variant, Gottlieb said that there are three questions. First, “is it more contagious?”

 

Former FDA Head: Immunity From Omicron Likely ‘Protective Against’ New Variant; ‘Doesn’t Appear To Be’ More Virulent

Former FDA Head: Immunity From Omicron Likely ‘Protective Against’ New Variant; ‘Doesn’t Appear To Be’ More Virulent

Avoid Global Biometric Identity Schemes

The global infrastructure for machine-biometric tracking made…
Former FDA Head: Immunity From Omicron Likely ‘Protective Against’ New Variant; ‘Doesn’t Appear To Be’ More Virulent

Backing a Brexit-like Referendum

Nigel Farage, one of the main promoters of the Brexit campaign,…
Former FDA Head: Immunity From Omicron Likely ‘Protective Against’ New Variant; ‘Doesn’t Appear To Be’ More Virulent

China on Track for 1,000 Warheads by 2030

The Chinese military is rapidly building up its strategic…